The RoPlaVac Project, which is a spin off company of iMM Lisboa, aims to develop and validate a novel vaccination strategy against malaria, one of the world's deadliest diseases. RoPlaVac is developing a new whole-organism vaccine against malaria based on the use of genetically modified rodent Plasmodium parasites, as well as a method to cryopreserve Plasmodium sporozoites for use in research and vaccination.

The RoPlaVac Project, which is a spin off company of iMM Lisboa, aims to develop and validate a novel vaccination strategy against malaria, one of the world's deadliest diseases. RoPlaVac is developing a new whole-organism vaccine against malaria bas...Show all

Company (Alive / Active)

Phone: +(351) 217 999 411

Fax:

Faculdade de Medicina da Universidade de Lisboa

Lisbon, 1649-028
Portugal

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
RoPlaVac $0M Jun 6, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related RoPlaVac Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)